Home » 23andMe, MyoKardia to Create Hypertrophic Cardiomyopathy Patient Community

23andMe, MyoKardia to Create Hypertrophic Cardiomyopathy Patient Community

Oct 25, 2018
|
staff reporter

NEW YORK (GenomeWeb) – MyoKardia said today that it is collaborating with 23andMe to create a patient community to advance research into hypertrophic cardiomyopathy (HCM), a progressive and frequently debilitating disease characterized by excessive contractility of the heart.

Under the terms of the partnership, the companies will create a patient community where 23andMe customers can access regularly updated disease information and HCM research opportunities. The companies noted that more than 6,000 HCM patients are currently 23andMe customers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Critics Say Open-Access Plan 'Goes Too Far'

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

Science and the Science Committee

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

And Gone

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

This Week in PLOS

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.

What's Popular?

In Informatics

  1. Bacterial Classification Could Be Compromised as RefSeq Database Grows

    Premium

  2. Scripps-Nvidia Partnership Melding Genomics, Sensor Data

    Premium

  3. WUSTL Software Offers Automated Option for Cancer Variant Review

    Premium

  4. PerkinElmer Adopts BioDiscovery Software for Genomic Data Analysis

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.